We are leading the technological development, manufacturing, and commercialization of technology in the fields of multiplex immunoblot,
point-of-care testing(POCT), and digital healthcare(Digital healthcare & Home testing)
based on BT/NT/IT/AI convergence technology.
Immunoblot
Point-of-care testing
Home test
The in vitro diagnostic industry is entering the telemedicine era for customized diagnosis and healthcare by incorporating information technologies, such as Internet of Things(IoT) and AI, in response to the demand for multiplex, high-throughput sample processing, miniaturization, and POCT.
We are implementing a smart digital healthcare system that can predict, prevent, diagnose, customize prescriptions, and monitor post-treatment by integrating these technologies and using multiplexed immunoblot systems, field diagnosis systems, and digital healthcare systems in a complementary manner.
Field of business
We are personalizing diagnosis by using a commercialized platform based on the convergence of bio, nano, and IT technologies in a complementary manner.
Multiplexed immunoblot system
for general hospitals
and examination centers
Multiplexed immunoblot is an in vitro diagnostic medical device used in diagnostic laboratories of general hospitals and examination centers. We have established a globally allergy diagnostic lineup based on our independently developed multi-immuno products and reagents. Through this, we can supply customized panels for each country. It also has substantial growth potential in the allergy, food intolerance, and autoimmune disease diagnostic markets.
Multiplexed immunoblot reagents include products that can diagnose more than 100 types of allergens, and products that can test various anti-nuclear antibody-related auto-antibodies associated with systemic autoimmune diseases.
Automated diagnostic equipment provides full automation of multi-immuno diagnostic strips and reagents, analysis of results, recognition of specimen IDs, and dispensing of samples, as well as semi-automated equipment that dispenses specimens manually. It also includes analysis software and readers to support more accurate and efficient diagnosis.
POCT system
for small- and
medium-sized hospitals
POCT products are for rapid and easy diagnosis of diseases in the field.
We develop and commercialize in vitro POCT diagnostic reagents. Our main products include the COVID-19-related rapid antigen test kit, the SGTi-flex line for infectious diseases, such as influenza, as well as the INCLIX line for quantitative testing of diabetes, cardiovascular disease, and hormones.
We also provide in vitro diagnostic equipment including INCLIX, which is a device that can analyze gold nanoparticle-based immunochromatography strips, and INCLIX F-100, which is an immunochromatography analysis device that can measure high sensitivity TRF systems and fluorescence.
Home/personal mobile
diagnostic system
We are leading changes in the medical paradigm through personalized diagnostic technology. Surearly SMART, the flagship product, accurately diagnoses and monitors diseases of females by analyzing the urine concentration patterns of five female hormones. This enables continuous health management throughout female life cycles.
Introduction of the concept of self-diagnosis can create a new market and is expected to be useful as a prescription-based self-diagnosis system. Currently, there is no product on the market that can diagnose the health of females by testing five female hormones. Surearly SMART is expected to be competitive through the use of innovative diagnostic technologies, such as an ultra-small low-power analysis system, sandwich immunoassay, and competitive immunoassay.